ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 106 - 120 of 5996 products
Eluminex Starts Trials of Novel Trispecific Fusion mAb for Macular Edema
$5.00
Available
SCG and A*STAR to Develop better Stem Cell Manufacturing in Singapore
$5.00
Available
WuXi AppTec Says Q1 Revenues Hit Targets, Clients not Leaving Company
$5.00
Available
Brise Pharma Closes $20 Million in A Rounds for Novel Pain Drugs
$5.00
Available
Transcenta and Agilent Collaborate on Companion Diagnostic for Claudin18.2 mAb
$5.00
Available
YS Biopharma Says PIKA Rabies Vaccine Effective after One-Week Dosing
$5.00
Available
Abbisko Completes Enrollment in Global Phase III Trial for Tenosynovial Giant Cell Tumor
$5.00
Available
Kelun/Merck Release Positive Early Data on TROP-2 ADC for Gastric Cancer
$5.00
Available
Kexing Biopharm’s Phase III Trial of Inhaled RSV Therapy for Children
$5.00
Available
VesiCURE Says Stem Cell Derived Extracellular Vesicles Effective in UC
$5.00
Available
Sino Biopharm to Partner China Development of Boehringer Ingelheim Portfolio
$5.00
Available
Junshi's Eighth China Approval of PD-1 is for Renal Cell Carcinoma
$5.00
Available
D3 Bio Raises $62 Million in Series A+ Round for Next-Gen KRAS G12C Inhibitor
$5.00
Available
Visen Pharma Plans Hong Kong IPO to Support Endocrine Therapies
$5.00
Available
Aurisco Pharma Expands Yangzhou CRDMO Facility for Generic GLP-1 Peptides
$5.00
Available